Research ArticleMethodology
Development and Biologic Evaluation of a Kit for Preformed Chelate Technetium-99m Radiolabeling of an Antibody Fab Fragment Using a Diamide Dimercaptide Chelating Agent
Sudhakar Kasina, Tripuraneni N. Rao, Ananthachari Srinivasan, James A. Sanderson, Jeffrey N. Fitzner, John M. Reno, Paul L. Beaumier and Alan R. Fritzberg
Journal of Nuclear Medicine July 1991, 32 (7) 1445-1451;
Sudhakar Kasina
Tripuraneni N. Rao
Ananthachari Srinivasan
James A. Sanderson
Jeffrey N. Fitzner
John M. Reno
Paul L. Beaumier
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Development and Biologic Evaluation of a Kit for Preformed Chelate Technetium-99m Radiolabeling of an Antibody Fab Fragment Using a Diamide Dimercaptide Chelating Agent
Sudhakar Kasina, Tripuraneni N. Rao, Ananthachari Srinivasan, James A. Sanderson, Jeffrey N. Fitzner, John M. Reno, Paul L. Beaumier, Alan R. Fritzberg
Journal of Nuclear Medicine Jul 1991, 32 (7) 1445-1451;
Development and Biologic Evaluation of a Kit for Preformed Chelate Technetium-99m Radiolabeling of an Antibody Fab Fragment Using a Diamide Dimercaptide Chelating Agent
Sudhakar Kasina, Tripuraneni N. Rao, Ananthachari Srinivasan, James A. Sanderson, Jeffrey N. Fitzner, John M. Reno, Paul L. Beaumier, Alan R. Fritzberg
Journal of Nuclear Medicine Jul 1991, 32 (7) 1445-1451;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Past, Present, and Future of Annexin A5: From Protein Discovery to Clinical Applications
- 186Rhenium-labeled anti-CD20 antibody radioimmunotherapy followed by autologous peripheral blood stem cell transplantation in patients with relapsed or refractory non-Hodgkin lymphoma
- Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis
- Selective Uptake of Radiolabeled Annexin V on Acute Porcine Left Atrial Thrombi